PMR, or polymyalgia rheumatica, is diagnosed through a combination of symptoms, blood tests, and ruling out other conditions. There is no single definitive test for it. Instead, doctors use a pattern of clinical findings, most notably bilateral shoulder pain, elevated inflammation markers, and a rapid response to low-dose corticosteroids, to confirm the diagnosis.
Who Gets PMR
PMR almost exclusively affects people over 50, and incidence rates climb significantly with age. It is more common in women than men, and population studies in the UK show higher rates in certain regions, suggesting both genetic and environmental factors play a role. If you’re under 50 and experiencing similar symptoms, your doctor will likely look for a different explanation.
The Core Symptoms Doctors Look For
The hallmark of PMR is bilateral shoulder aching, meaning both shoulders hurt. This isn’t the kind of soreness you get from overdoing it at the gym. It comes on relatively quickly, usually developing over days to weeks, and is accompanied by profound stiffness, particularly in the morning. To meet the classification criteria established by European and American rheumatology organizations, that morning stiffness needs to last longer than 45 minutes.
Hip pain and limited hip movement are also common. Many people describe difficulty raising their arms above their heads, getting out of a chair, or rolling over in bed. The pain tends to be worst after periods of rest and can significantly disrupt sleep. Fatigue, low-grade fever, and unintentional weight loss sometimes accompany the joint and muscle symptoms.
One important distinction: PMR typically does not cause swelling in the small joints of the hands and feet. If those joints are affected, your doctor may suspect rheumatoid arthritis instead.
Blood Tests That Support the Diagnosis
Two blood markers play a central role in PMR diagnosis: ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein). Both measure general inflammation in the body. In PMR, the ESR frequently exceeds 40 mm/hr and can climb above 100 mm/hr. CRP levels are often elevated as well and tend to track alongside ESR.
That said, these markers aren’t perfectly reliable. Between 7 and 20 percent of PMR patients have only mildly elevated ESR, and occasionally it’s completely normal, particularly in people with limited disease activity. Abnormal ESR or CRP alone doesn’t confirm PMR either, since many conditions raise inflammation markers. These tests support the diagnosis but don’t make it on their own.
Doctors also typically check for rheumatoid factor and a related antibody called ACPA. In PMR, both are usually negative. Their absence actually counts toward the diagnosis: in the formal scoring system, negative results for these markers contribute two points toward the diagnostic threshold. A positive rheumatoid factor, on the other hand, raises suspicion for late-onset rheumatoid arthritis.
How the Scoring System Works
The 2012 classification criteria developed jointly by European and American rheumatology organizations use a point-based system. To even apply the criteria, a patient must be 50 or older, have new-onset bilateral shoulder pain (present for less than 12 weeks), and show abnormal CRP or ESR. If those baseline requirements are met, the scoring begins:
- Morning stiffness lasting more than 45 minutes: 2 points
- Hip pain or limited hip range of motion: 1 point
- Negative rheumatoid factor and/or ACPA: 2 points
- Absence of other peripheral joint pain: 1 point
A score of 4 or higher suggests PMR, with 68% sensitivity and 78% specificity. When ultrasound findings are added to the evaluation, a score of 5 or higher improves specificity to 81%. These numbers mean the criteria are good at confirming PMR but aren’t perfect. Some people with genuine PMR won’t meet the threshold, and a small number of people with other conditions may score high enough to be misclassified.
The Role of Ultrasound
Ultrasound imaging can strengthen the diagnosis by revealing specific patterns of inflammation. In PMR, ultrasound commonly shows bursitis in the subacromial-subdeltoid bursa (the fluid-filled sac near the top of the shoulder), inflammation around the long head of the biceps tendon, and synovitis in the back and bottom portions of the shoulder joint. These findings help differentiate PMR from conditions like frozen shoulder, which can cause similar bilateral pain but produces different ultrasound patterns.
Ultrasound isn’t required for diagnosis, but it adds confidence when the clinical picture is ambiguous.
What Has to Be Ruled Out First
PMR is a diagnosis that can only be made after other explanations have been excluded. The classification criteria explicitly state they should not be applied if the symptoms are better explained by something else. Conditions that can mimic PMR include late-onset rheumatoid arthritis, infections, thyroid disorders, and certain cancers.
Distinguishing PMR from late-onset rheumatoid arthritis is one of the trickiest challenges. Bilateral upper arm tenderness, a negative rheumatoid factor, and the absence of small joint swelling are the most valuable features pointing toward PMR rather than rheumatoid arthritis. However, some patients who initially appear to have PMR go on to develop full rheumatoid arthritis. The only early feature that reliably predicts this progression is peripheral synovitis (swelling in joints outside the shoulders and hips), and even that has limited predictive value.
The Prednisone Test
One of the most distinctive features of PMR is how dramatically it responds to low-dose corticosteroids. Most people feel rapid relief from pain and stiffness within one to three days of starting prednisone. This quick response is so characteristic that it’s sometimes used as a diagnostic tool in itself. If a patient with a classic PMR presentation doesn’t improve noticeably within a few days of starting corticosteroids, the diagnosis should be reconsidered.
This doesn’t mean prednisone is a short-term fix. Most people with PMR need to stay on corticosteroids for one to two years, with the dose gradually tapered down. Stopping too quickly often triggers a relapse.
The Connection to Giant Cell Arteritis
About 16.5% of people with PMR also develop giant cell arteritis (GCA), a condition involving inflammation of the blood vessels, particularly the arteries in the temples and head. In a retrospective analysis, GCA developed alongside the PMR diagnosis in about 40% of those cases and after the PMR diagnosis in 51%. Estimates across different studies range from 5 to 30 percent, depending on the population studied.
This overlap matters because GCA carries serious risks, including vision loss if untreated. One research group found that a CRP level above 26.5 mg/L in newly diagnosed PMR patients had moderate accuracy for identifying those with concurrent, undetected GCA. If you develop new headaches, scalp tenderness, jaw pain while chewing, or vision changes after a PMR diagnosis, these symptoms need prompt evaluation.